IBDEI27F ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36998,2)
 ;;=^5063430
 ;;^UTILITY(U,$J,358.3,36999,0)
 ;;=Z85.79^^169^1865^28
 ;;^UTILITY(U,$J,358.3,36999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36999,1,3,0)
 ;;=3^Personal history of malignant neoplasm of lymphoid, hematpoetc & rel tiss
 ;;^UTILITY(U,$J,358.3,36999,1,4,0)
 ;;=4^Z85.79
 ;;^UTILITY(U,$J,358.3,36999,2)
 ;;=^5063437
 ;;^UTILITY(U,$J,358.3,37000,0)
 ;;=Z85.831^^169^1865^29
 ;;^UTILITY(U,$J,358.3,37000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37000,1,3,0)
 ;;=3^Personal history of malignant neoplasm of soft tissue
 ;;^UTILITY(U,$J,358.3,37000,1,4,0)
 ;;=4^Z85.831
 ;;^UTILITY(U,$J,358.3,37000,2)
 ;;=^5063445
 ;;^UTILITY(U,$J,358.3,37001,0)
 ;;=Z85.71^^169^1865^1
 ;;^UTILITY(U,$J,358.3,37001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37001,1,3,0)
 ;;=3^Personal history of Hodgkin lymphoma
 ;;^UTILITY(U,$J,358.3,37001,1,4,0)
 ;;=4^Z85.71
 ;;^UTILITY(U,$J,358.3,37001,2)
 ;;=^5063435
 ;;^UTILITY(U,$J,358.3,37002,0)
 ;;=Z85.830^^169^1865^30
 ;;^UTILITY(U,$J,358.3,37002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37002,1,3,0)
 ;;=3^Personal history of malignant neoplasm of bone
 ;;^UTILITY(U,$J,358.3,37002,1,4,0)
 ;;=4^Z85.830
 ;;^UTILITY(U,$J,358.3,37002,2)
 ;;=^5063444
 ;;^UTILITY(U,$J,358.3,37003,0)
 ;;=Z85.820^^169^1865^2
 ;;^UTILITY(U,$J,358.3,37003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37003,1,3,0)
 ;;=3^Personal history of malignant melanoma of skin
 ;;^UTILITY(U,$J,358.3,37003,1,4,0)
 ;;=4^Z85.820
 ;;^UTILITY(U,$J,358.3,37003,2)
 ;;=^5063441
 ;;^UTILITY(U,$J,358.3,37004,0)
 ;;=Z85.828^^169^1865^31
 ;;^UTILITY(U,$J,358.3,37004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37004,1,3,0)
 ;;=3^Personal history of malignant neoplasm of skin NEC
 ;;^UTILITY(U,$J,358.3,37004,1,4,0)
 ;;=4^Z85.828
 ;;^UTILITY(U,$J,358.3,37004,2)
 ;;=^5063443
 ;;^UTILITY(U,$J,358.3,37005,0)
 ;;=Z85.840^^169^1865^32
 ;;^UTILITY(U,$J,358.3,37005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37005,1,3,0)
 ;;=3^Personal history of malignant neoplasm of eye
 ;;^UTILITY(U,$J,358.3,37005,1,4,0)
 ;;=4^Z85.840
 ;;^UTILITY(U,$J,358.3,37005,2)
 ;;=^5063446
 ;;^UTILITY(U,$J,358.3,37006,0)
 ;;=Z85.841^^169^1865^33
 ;;^UTILITY(U,$J,358.3,37006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37006,1,3,0)
 ;;=3^Personal history of malignant neoplasm of brain
 ;;^UTILITY(U,$J,358.3,37006,1,4,0)
 ;;=4^Z85.841
 ;;^UTILITY(U,$J,358.3,37006,2)
 ;;=^5063447
 ;;^UTILITY(U,$J,358.3,37007,0)
 ;;=Z85.848^^169^1865^34
 ;;^UTILITY(U,$J,358.3,37007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37007,1,3,0)
 ;;=3^Personal history of malignant neoplasm of prt nervous tissue
 ;;^UTILITY(U,$J,358.3,37007,1,4,0)
 ;;=4^Z85.848
 ;;^UTILITY(U,$J,358.3,37007,2)
 ;;=^5063448
 ;;^UTILITY(U,$J,358.3,37008,0)
 ;;=Z85.850^^169^1865^35
 ;;^UTILITY(U,$J,358.3,37008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37008,1,3,0)
 ;;=3^Personal history of malignant neoplasm of thyroid
 ;;^UTILITY(U,$J,358.3,37008,1,4,0)
 ;;=4^Z85.850
 ;;^UTILITY(U,$J,358.3,37008,2)
 ;;=^5063449
 ;;^UTILITY(U,$J,358.3,37009,0)
 ;;=Z85.858^^169^1865^36
 ;;^UTILITY(U,$J,358.3,37009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37009,1,3,0)
 ;;=3^Personal history of malignant neoplasm of endocrine glands
 ;;^UTILITY(U,$J,358.3,37009,1,4,0)
 ;;=4^Z85.858
 ;;^UTILITY(U,$J,358.3,37009,2)
 ;;=^5063450
 ;;^UTILITY(U,$J,358.3,37010,0)
 ;;=20550^^170^1866^29^^^^1
 ;;^UTILITY(U,$J,358.3,37010,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,37010,1,2,0)
 ;;=2^TENDON SHEATH/LIGAMENT/CYST
 ;;^UTILITY(U,$J,358.3,37010,1,3,0)
 ;;=3^20550
 ;;^UTILITY(U,$J,358.3,37011,0)
 ;;=20600^^170^1866^9^^^^1
